Tag Archives: patients.
Displays Navigator valsartan has delayed the progression to type 2 diabetes in patients at risk cardiovascular patients with impaired. . .
NAVIGATOR Shows Valsartan Delayed Progression To Type 2 Diabetes In At-Risk Cardiovascular Patients With Impaired …
Results from a landmark study involving more than 9,000 people showed that the high blood pressure medicine valsartan delayed progression to type 2 diabetes in patients with cardiovascular disease or risk factors and impaired glucose tolerance (IGT), a common pre-diabetic [...]
Study shows valsartan NAVIGATOR delayed the progression to type 2 diabetes in patients with cardio-vascular
NAVIGATOR trial shows valsartan delayed progression to type 2 diabetes in cardiovascular patients
Results from a landmark study involving more than 9,000 people showed that the high blood pressure medicine valsartan delayed progression to type 2 diabetes in patients with cardiovascular disease or risk factors and impaired glucose tolerance (IGT), a common pre-diabetic condition.
Read more on [...]
Tolerx published monitoring data of the study otelixizumab therapy for patients at the onset T1DM
Tolerx publishes follow-up data from study of otelixizumab therapy for new onset T1DM patients
Tolerx, Inc., today announced the publication in Diabetologia, the journal of the European Association for the Study of Diabetes, of the four-year follow-up clinical data from new onset type 1 diabetes (T1DM) patients (age 12-39) who received a single short course of [...]
Set fat glycemic, BP goals in diabetic patients. : An article from: Family Practice News
Product DescriptionThis digital document is an article from Family Practice News, published by International Medical News Group June 15, 2000. The length of the article is 855 words. The site is presented in detail displayed is based on a typical 300 pages of text. The article is delivered in HTML format and is available in [...]